HIV/AIDS Therapy
Perirenal fat diameter early predictor of HAART-associated lipodystrophy
Published in AIDS Weekly, September 20th, 2004
"Echographically measured thicknesses of perirenal and subcutaneous fat, as well as serum metabolic and anthropometric parameters, were evaluated in 74 human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy (HAART), 22 of whom were HAART-naive at baseline, who were followed-up for 27 months to detect predictive factors of lipodystrophy," researchers in Spain report.
"Perirenal fat diameter (PRFD) at baseline differed in HAART-naive and HAART-experienced patients (P < .001),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-09-20)
More Articles from AIDS Weekly
- HIV/AIDS Gene Therapy
Novel target site for gene therapy may control/manage HIV-1 infection - HIV/AIDS Research
Progenitor cells may be a reservoir for HIV-1 in the brains of infected patients - HIV/AIDS Research
Replication-competent HIV-2 found in patients with undetectable viremia - HIV/AIDS Therapy
Mycophenolate mofetil and HAART delays viral load rebound in HIV infection - AIDS Vaccine
Promising results announced for novel vaccine technology - AIDS/HIV Vaccine
Fowlpox viruses carrying multiple vaccine antigens constructed - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
